PEGCETACOPLAN
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Return from PBS-subsidised eculizumab post pregnancy or from one of the PBS-subsidised
therapies for this condition, for reasons other than post pregnancy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,343.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - Initial 2 (switching from a Complement 5 (C5) inhibitor)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,343.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: First continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Subsequent continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangement 1
(Complement 5 (C5) inhibitor inexperienced patients)
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangement 2
(Complement 5 (C5) inhibitor experienced patients)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $4,343.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Return from PBS-subsidised eculizumab post pregnancy or from one of the PBS-subsidised
therapies for this condition, for reasons other than post pregnancy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,392.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - Initial 2 (switching from a Complement 5 (C5) inhibitor)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,392.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: First continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Subsequent continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangement 1
(Complement 5 (C5) inhibitor inexperienced patients)
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangement 2
(Complement 5 (C5) inhibitor experienced patients)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $4,392.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - Initial 1 (new untreated patient)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,392.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - Initial 1 (new untreated patient)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,343.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||